Tech Center 1600 • Art Units: 1633
This examiner grants 77% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18285000 | MODIFIED VIRUSES AND VIRAL PARTICLES, METHODS OF MAKING, AND USES THEREOF | Non-Final OA | The Regents of the University of California |
| 18551562 | RECOMBINANT VIRAL EXPRESSION VECTORS AND METHODS OF USE | Non-Final OA | North Carolina State University |
| 17685457 | ADENO-ASSOCIATED VIRUS FOR DELIVERY OF KH902 (CONBERCEPT) AND USES THEREOF | Final Rejection | University of Massachusetts |
| 18010964 | GENETICALLY MODIFIED NON-HUMAN ANIMAL EXPRESSING A B2M/FCRN FUSION PROTEIN | Non-Final OA | Biocytogen Pharmaceuticals (Beijing) Co., Ltd. |
| 18273441 | MATURATION AGENT | Non-Final OA | Orizuru Therapeutics, Inc. |
| 18028464 | USE OF COMPOUND FOR IMPROVING TRANSPLANTATION EFFICIENCY OF HUMAN HEMATOPOIETIC STEM CELLS | Non-Final OA | EDIGENE (GUANGZHOU) INC. |
| 17670789 | Novel oncolytic parvoviruses with enhanced cargo capacity, stable shRNA expression cassette and novel immunogenic properties | Final Rejection | Alliance of Cardiovascular Researchers |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy